Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

N. Personeni, L. Giordano, G. Abbadessa, C. Porta, I. Borbath, B. Daniele, J.-L. Van Laethem, H. Van Vlierberghe, J. Trojan, E.N. De Toni, A. Gasbarrini, M. Lencioni, M.E. Lamar, Y. Wang, D. Shuster, B. Schwartz, A. Santoro, L. Rimassa

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)14408-14415
Number of pages8
JournalOncotarget
Volume8
Issue number9
DOIs
Publication statusPublished - 2017

Cite this

Personeni, N., Giordano, L., Abbadessa, G., Porta, C., Borbath, I., Daniele, B., Van Laethem, J-L., Van Vlierberghe, H., Trojan, J., De Toni, E. N., Gasbarrini, A., Lencioni, M., Lamar, M. E., Wang, Y., Shuster, D., Schwartz, B., Santoro, A., & Rimassa, L. (2017). Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. Oncotarget, 8(9), 14408-14415. https://doi.org/10.18632/oncotarget.14797